Hester Pharmaceuticals Ltd has announced that the Company had undertaken for its production capacity from 1200 million closes to 4800 million closes of poultry vaccines.
The expanded capacity has now been commissioned. The trial cum commercial production has commenced from March 23, 2007.
This increased capacity includes the scope for manufacturing a few large animal vaccines.